Enoxaparin sodium
- Generic Name
- Enoxaparin sodium
- Brand Names
- Lovenox, Inhixa
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 9005-49-6
- Unique Ingredient Identifier
- E47C0NF7LV
- Background
Enoxaparin is a common low-molecular-weight heparin (LMWH) used in the prevention and management of various thromboembolic disorders. Initially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies. Enoxaparin markedly reduces the incidence of venous thromboembolism in hosp...
- Indication
Enoxaparin is indicated for the prevention of ischemic complications in unstable angina and in non Q-wave myocardial infarction; it is indicated in conjunction with percutaneous intervention and/or other treatment for the management of acute ST elevation myocardial infarction.
...
- Associated Conditions
- Acute Coronary Syndrome (ACS), Acute Myocardial Infarction With ST Segment Elevation, Deep Vein Thrombosis, Ischemic complications caused by non-q wave myocardial infarction, Ischemic complications caused by unstable angina
- Associated Therapies
- Percutaneous Coronary Intervention (PCI)
Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial
- First Posted Date
- 2023-05-26
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- University Hospital, Geneva
- Target Recruit Count
- 77
- Registration Number
- NCT05878899
- Locations
- 🇨🇭
Geneva University Hospitals, Geneve, Switzerland
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 6660
- Registration Number
- NCT05735639
- Locations
- 🇬🇧
Imperial College Hospital NHS Foundation Trust, London, United Kingdom
A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants
- Conditions
- Interventions
- First Posted Date
- 2022-11-16
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 373
- Registration Number
- NCT05618808
- Locations
- 🇧🇬
MBAL Heart and Brain Hospital, Pleven, Bulgaria
🇧🇪Ziekenhuis Oost-Limburg- Campus Sint-Jan, Genk, Limburg, Belgium
🇭🇺Department of Orthopedics, Somogy County Mór Kaposi Teaching Hospital, Kaposvar, Hungary
Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury
- Conditions
- Interventions
- First Posted Date
- 2022-08-02
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Loewenstein Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05484557
- Locations
- 🇮🇱
Loewenstein Rehabilitation Hospital, Ra'anana, Israel
Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- RAAS Nutritionals, LLC
- Target Recruit Count
- 71
- Registration Number
- NCT05417997
- Locations
- 🇹🇷
Kayseri City Hospital, Kayseri, Kayseri Province, Turkey
Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
- Conditions
- Interventions
- First Posted Date
- 2022-04-19
- Last Posted Date
- 2022-08-19
- Lead Sponsor
- University Magna Graecia
- Target Recruit Count
- 58
- Registration Number
- NCT05334654
- Locations
- 🇮🇹
AOU Mater Domini, Catanzaro, Italy
Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment
- Conditions
- Interventions
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2022-09-10
- Lead Sponsor
- Faculdade de Medicina do ABC
- Target Recruit Count
- 104
- Registration Number
- NCT05225155
- Locations
- 🇧🇷
Assistencia Materno Infantil Lambert, Santo Andre, SP, Brazil
Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
- Conditions
- Interventions
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 813
- Registration Number
- NCT05224388
- Locations
- 🇧🇪
Ghent University Hospital, Gent, Belgium
Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2022-03-21
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 500
- Registration Number
- NCT05203705
- Locations
- 🇨🇳
Perking Union Medical College Hospital, Beijing, Beijing, China
Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2021-12-29
- Target Recruit Count
- 94
- Registration Number
- NCT05172115
- Locations
- 🇮🇷
Rajaie Cardiovascular Medical and Research Center, Tehran, Iran, Islamic Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.